George Adi Mor sold $1.2M of CMMB
Chief Scientific Officer at Chemomab Therapeutics Ltd.. 582,023 shares at an average of $2.08, traded Nov 16, 2022, filed Nov 17, 2022.
Score components
- +15RoleOfficer
- +25Trade size$1.2M at market
- +20Share of holdings soldSold 90% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001178913-22-004098, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 16, 2022 | SOpen-market sale American Depositary Shares | -324,775 | $2.08 | $677k | 324,775 | Nov 17, 2022 |
| Nov 16, 2022 | SOpen-market sale American Depositary Sharesindirect: By Spouse | -257,248 | $2.08 | $536k | 257,247 | Nov 17, 2022 |
| Mar 15, 2018 | AGrant or award Option to Purchase American Depositary Sharesderivative | +131,698 | $0.00 | $0 | 131,698 | Nov 17, 2022 |
| Oct 28, 2016 | AGrant or award Option to Purchase American Depositary Sharesderivativeindirect: By Kobi George, the Reporting Person's spouse | +33,725 | $0.00 | $0 | 33,725 | Nov 17, 2022 |
Related signals
Other insiders at Chemomab Therapeutics Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | CMMBsell Chemomab Therapeutics Ltd. | Neil Harris Cohen director | $6,516 2,304 shares | -7% | |
| 36Weak | CMMBbuy Chemomab Therapeutics Ltd. | George Adi Mor Chief Executive Officer | $20k 9,804 shares | +8% | |
| 28Weak | Chemomab Therapeutics Ltd. | Neil Harris Cohen director | $4,818 2,409 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.